Abstract:Tumorigenesis is a complex and dynamic process involving cell-cell and cell-extracellular matrix (ECM) interactions that allow tumor cell growth, drug resistance and metastasis. This review provides an updated summary of the role played by the tumor microenvironment (TME) components and hypoxia in tumorigenesis, and highlight various ways through which tumor cells reprogram normal cells into phenotypes that are pro-tumorigenic, including cancer associated- fibroblasts, -macrophages and -endothelial cells. Tumor cells secrete numerous factors leading to the transformation of a previously anti-tumorigenic environment into a pro-tumorigenic environment. Once formed, solid tumors continue to interact with various stromal cells, including local and infiltrating fibroblasts, macrophages, mesenchymal stem cells, endothelial cells, pericytes, and secreted factors and the ECM within the tumor microenvironment (TME). The TME is key to tumorigenesis, drug response and treatment outcome. Importantly, stromal cells and secreted factors can initially be anti-tumorigenic, but over time promote tumorigenesis and induce therapy resistance. To counter hypoxia, increased angiogenesis leads to the formation of new vascular networks in order to actively promote and sustain tumor growth via the supply of oxygen and nutrients, whilst removing metabolic waste. Angiogenic vascular network formation aid in tumor cell metastatic dissemination. Successful tumor treatment and novel drug development require the identification and therapeutic targeting of pro-tumorigenic components of the TME including cancer-associated- fibroblasts (CAFs) and -macrophages (CAMs), hypoxia, blocking ECM-receptor interactions, in addition to the targeting of tumor cells. The reprogramming of stromal cells and the immune response to be anti-tumorigenic is key to therapeutic success. Lastly, this review highlights potential TME- and hypoxia-centered therapies under investigation.

The tumor microenvironment and metastatic disease

The hypoxic tumour microenvironment and metastatic progression

Pathophysiological Basis for the Formation of the Tumor Microenvironment

Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment

Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications

The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited

Interplay between Solid Tumors and Tumor Microenvironment

Interactions between Tumor Cells and Host Microenvironment will Determine the Fate of Metastasis

Tumor Microenvironment: the Culprit for Ovarian Cancer Metastasis?

The influence of pH and hypoxia on tumor metastasis

The lung microenvironment: an important regulator of tumour growth and metastasis

The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets

Critical steps to tumor metastasis: alterations of tumor microenvironment and extracellular matrix in the formation of pre-metastatic and metastatic niche

Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis

The tumor microenvironment and its role in promoting tumor growth

Role of the Tumor Microenvironment in Tumor Progression and the Clinical Applications (Review).

Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment

Hypoxia and Metabolism in Metastasis

Biophysical interplay between extracellular matrix remodeling and hypoxia signaling in regulating cancer metastasis

Tumor microenvironment: A playground for cells from multiple diverse origins